MedAxiom Recruits Test Sites for Peer Review Plus, World’s First Crowdsourced Clinical Performance and Case Evaluation Solution

Revolutionary Platform Eliminates Bias While Reducing External Costs, Standardizes Processes and Reporting

NEPTUNE BEACH, Fla.--()--MedAxiom, the cardiovascular community’s premier destination for organizational performance solutions, has developed Peer Review Plus, the world’s first clinical peer review solution to effectively and efficiently conduct unbiased performance evaluations and case reviews with input from a nationwide network of peers. MedAxiom is currently recruiting healthcare organizations to test the product, offering two-year free access as just one benefit of participation.

Nearly one trillion dollars a year are wasted due to administrative complexity, fraud and abuse, and failure of care delivery and coordination. Further, competition, bureaucracy and legal challenges make safe and objective feedback and improvement difficult. Powered by MedAxiom Platforms, LLC, Peer Review Plus revolutionizes the required peer review process, created 70 years ago to standardize medical services and protect patients in the U.S.

“It’s no secret that the peer review system in the U.S. is broken. Peer Review Plus is built on three pillars that revolutionize the current practice of performance and case evaluations. The platform is designed to be easy and efficient, eliminate bias and standardize processes and reporting. Peer Review Plus harnesses the wisdom of crowds and anonymization to introduce outside perspectives and build a forum to disseminate best practices,” said Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom.

The Peer Review Plus platform is intuitive, secure and entirely digitized. It is also able to meet all state standards to remain protected from discovery. When a case needs to be reviewed, clients will be able to have case details protected health information (PHI) auto-redacted per HIPAA compliance and for anonymity. The system uses advanced metrics and data analysis to randomize case allocation and ensure that only external physicians at another institution review each case. Reviewers submit their analyses using a proprietary standardized review tool that converts results into straightforward scoring. The platform then aggregates the results and sends one easy-to-digest report.

MedAxiom invites testers to join a sophisticated network of peers driving value-based care, medical precision and better patient outcomes. Learn more about the platform and testing participation at

About MedAxiom

MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience. For additional information, visit


Courtney Stuntz

Social Media Profiles


Courtney Stuntz